Inventor · disambiguated record
Doriano Fabbro
Also filed as: FABBRO DORIANO
14 granted patents·16 pending applications·144 citations·filing 1996–2025
91Inventor score
Top patents by PatentIndex Score
30 records- 0188US11918586B2Treatment of skin lesionsTORQUR AG·Filed 2021·Granted Mar 5, 2024·2 cites·14 claims
- 0288US11878972B2Treatment of neurological disordersTORQUR AG·Filed 2020·Granted Jan 23, 2024·3 cites·20 claims
- 0388US5744460ACombination for treatment of proliferative diseasesNOVARTIS AG·Filed 1996·Granted Apr 28, 1998·89 cites·12 claims
- 0482US10993947B2Treatment of skin lesionsPIQUR THERAPEUTICS AG·Filed 2017·Granted May 4, 2021·2 cites·20 claims
- 0582US7666874B2Pyrimidylaminobenzamide derivatives for hypereosinophilic syndromeNOVARTIS AG·Filed 2006·Granted Feb 23, 2010·6 cites·4 claims
- 0680US8673930B2Pyrimidylaminobenzamide derivatives for systemic mastocytosisALLAND LEILA·Filed 2010·Granted Mar 18, 2014·6 cites·5 claims
- 0780US8119649B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2009·Granted Feb 21, 2012·1 cites·6 claims
- 0878US8124611B2Inhibitors of the mutant form of kitBUCHDUNGER ELISABETH·Filed 2010·Granted Feb 28, 2012·6 cites·2 claims
- 0976US11414426B2Treatment of skin disordersPIQUR THERAPEUTICS AG·Filed 2018·Granted Aug 16, 2022·2 cites·20 claims
- 1075US2024382496A1Treatment of skin lesionsTORQUR AG·Filed 2024·Application pending·0 cites
- 1173US8017621B2Inhibitors of the mutant form of kitNOVARTIS AG·Filed 2004·Granted Sep 13, 2011·6 cites·12 claims
- 1272US2024343718A1Treatment of neurological disordersTORQUR AG·Filed 2023·Application pending·0 cites
- 1371US12497407B2Treatment of skin disordersTORQUR AG·Filed 2022·Granted Dec 16, 2025·0 cites·16 claims
- 1469US2014303146A1Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic LeukemiasGRIFFIN JAMES DOUGLAS·Filed 2014·Application pending·0 cites
- 1568US2007149539A1Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2007·Application pending·0 cites
- 1667US2014057897A1Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemiasGRIFFIN JAMES DOUGLAS·Filed 2013·Application pending·0 cites
- 1764US8268837B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2005·Granted Sep 18, 2012·0 cites·1 claims
- 1864US2012329779A1Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic LeukemiasGRIFFIN JAMES DOUGLAS·Filed 2012·Application pending·0 cites
- 1959US2011009383A1Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemiasGRIFFIN JAMES DOUGLAS·Filed 2010·Application pending·0 cites
- 2059US2004248906A1Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemiaFiled 2002·Application pending·0 cites
- 2158US9700565B2Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemiasGRIFFIN JAMES DOUGLAS·Filed 2015·Granted Jul 11, 2017·0 cites·3 claims
- 2257US6291668B1Oligonucleotide derivativesNOVARTIS AG·Filed 1998·Granted Sep 18, 2001·21 cites·2 claims
- 2357US2007027167A1Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2006·Application pending·0 cites
- 2454US2008221080A1Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic LeukemiasGRIFFIN JAMES DOUGLAS·Filed 2003·Application pending·0 cites
- 2553US2025367210A1Treatment of squamous cell carcinomaPIQUR THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 2650US2021299133A1Treatment of squamous cell carcinomaPIQUR THERAPEUTICS AG·Filed 2019·Application pending·0 cites
- 2749US2008176879A1Pyrimidylaminobenzamide Derivatives For Sytemic MastocytosisALLAND LEILA·Filed 2006·Application pending·0 cites
- 2845US2019284178A1Treatment of neurological disordersPIQUR THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 2945US2012157441A1Inhibitors of the mutant form of kitBUCHDUNGER ELISABETH·Filed 2012·Application pending·0 cites
- 3035US2012015968A1Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper-and sterile alpha motif-containing kinase (zak)FABBRO DORIANO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Doriano Fabbro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →